article thumbnail

Study: Low RSV Vaccination Coverage Among Nursing Home Residents

Pharmacy Times

The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.

article thumbnail

Study Finds SARS-CoV-2 Booster Vaccination Lowers Infections, Hospitalizations, and Deaths in Nursing Homes

Pharmacy Times

There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nursing home groups decry mandate push by CMS for staff to get COVID-19 vaccine

Fierce Healthcare

Nursing home groups decry mandate push by CMS for staff to get COVID-19 vaccine. Thu, 08/19/2021 - 16:27.

article thumbnail

Vaccine experts urge more inclusivity in clinical trials

STAT

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. People who are immunocompromised and those who live in nursing homes were also not included.

Vaccines 135
article thumbnail

Vaccination Efforts to Mitigate Pneumococcal Outbreaks

Pharmacy Times

The panel of healthcare professionals examines how strategic vaccination can effectively mitigate pneumococcal outbreaks, thereby reducing exposure risks to vulnerable populations in healthcare settings such as nursing homes and hospitals.

article thumbnail

STAT+: Pharmalittle: Novartis is losing its chief commercial officer; vaccine experts urge more inclusivity in clinical trials

STAT

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the clinical trials that led to their approval — namely, that older adults were largely left out of them , STAT tells us.  Among Continue to STAT+ to read the full story…

Vaccines 111
article thumbnail

Lilly’s antibody for COVID-19 protection starts nursing home trial

pharmaphorum

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on.